Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: AB Science, Beigene, Bergenbio, Biontech, Entasis, First Wave, Gilead Sciences, Hightide, Pfizer, Shionogi, Transcenta, Turning Point, Veru, Zai Lab, Zymeworks.